Coluracetam 30 mg

Coluracetam (also known as BCI-540, MKC-231, N-[(2S,3R)-2,3,4-trihydroxy-3-(hydroxymethyl)cyclobutyl]-2-oxo-1-pyrrolidineacetamide) is a third-generation nootropic compound from the racetam family — structurally related to piracetam, but with a fundamentally different and far more targeted mechanism of action. Developed by Mitsubishi Tanabe Pharma and licensed to Bristol-Myers Squibb and Cognition Therapeutics, Coluracetam was originally designed as a therapeutic candidate for Alzheimer's disease, cognitive impairment, and glaucoma.
Unlike traditional racetams that primarily modulate AMPA receptors, Coluracetam is a high-affinity choline uptake (HACU) enhancer — it increases the rate at which neurons import choline from the extracellular space for acetylcholine synthesis. This makes it one of the most specific and potent cholinergic nootropics ever developed.
What Makes Coluracetam Unique? While most nootropics work by broadly modulating neurotransmitter systems, Coluracetam targets the bottleneck of acetylcholine production itself — the transport of choline into the presynaptic neuron. This gives it several distinct advantages:
·         Acetylcholine production is limited by choline availability — even if adequate choline is present in the blood, the neuron must actively transport it across the cell membrane via the HACU system. Coluracetam upregulates this transporter, effectively removing the rate-limiting step in acetylcholine synthesis
·         Selective action — it only enhances HACU when choline levels are low and acetylcholine demand is high, making it a "smart" nootropic that works when needed without causing cholinergic excess at baseline
·         Restorative effect — Coluracetam has been shown to restore HACU function in aging and degenerating neurons where choline transport machinery has become impaired — a mechanism lost in standard choline supplementation
Key Mechanisms of Action·         High-Affinity Choline Uptake (HACU) Enhancement — Coluracetam's primary and most unique mechanism. HACU is the rate-limiting step in acetylcholine synthesis, mediated by the choline transporter (CHT1) located on presynaptic cholinergic neuron terminals. Coluracetam potently and selectively upregulates CHT1 activity, increasing the maximum velocity (Vmax) of choline transport into the neuron. This directly translates to:
o    Increased acetylcholine production and release
o    Enhanced presynaptic cholinergic function
o    Restoration of impaired cholinergic transmission in aging neurons
o    Increased density of functional choline transporters
·         AMPA Receptor Modulation (Secondary) — Like many racetams, Coluracetam also has a modulatory effect on AMPA glutamate receptors (specifically the GluA1/GluA2 subunits), enhancing glutamatergic transmission and synaptic plasticity. This contributes to its pro-cognitive effects but is secondary to its HACU mechanism
·         NGF (Nerve Growth Factor) Potentiation — Preclinical studies suggest Coluracetam potentiates NGF signaling, supporting neuronal survival, axonal growth, and synaptic maintenance — especially in cholinergic neurons of the basal forebrain (the primary region affected in Alzheimer's disease)
·         Restoration of Impaired Cholinergic Function — In aging and degenerating neurons, HACU function progressively declines, leading to insufficient acetylcholine synthesis even when dietary choline is adequate. Coluracetam's ability to restore HACU function makes it uniquely suited for age-related cognitive decline — it doesn't just provide more choline, it repairs the machinery that uses it
·         Neuroprotection — By supporting cholinergic neuronal function, Coluracetam provides indirect neuroprotection against the cascade of damage that occurs when cholinergic neurons are compromised. It has been shown to protect against cholinergic cell death in multiple preclinical models of neurodegeneration
·         No Direct Effect on Neurotransmitter Receptors — Unlike most nootropics and pharmaceuticals, Coluracetam does not directly bind to neurotransmitter receptors (acetylcholine, dopamine, serotonin, etc.). This makes it exceptionally selective in its mechanism and reduces the risk of side effects associated with receptor-level modulation
·         Ocular Neuroprotection — Coluracetam has been investigated as a treatment for glaucoma due to its ability to protect retinal ganglion cells (which are cholinergic in nature) from degeneration. It supports visual function by enhancing cholinergic transmission in the retina and optic nerve
Key Benefits·         Superior Cognitive Enhancement — Users report significant improvements in working memory, verbal fluency, information processing speed, and mental clarity — often described as a "clean," non-stimulant cognitive enhancement without jitteriness or crash
·         Memory Consolidation — Particularly effective for encoding new memories and recalling information under demand. Beneficial for learning, studying, and knowledge work
·         Restoration of Cholinergic Function in Aging — Uniquely suited for age-related cognitive decline because it targets the root mechanism (impaired HACU) rather than just increasing choline supply
·         Non-Stimulating Focus — Unlike traditional stimulants (caffeine, modafinil, amphetamines), Coluracetam provides cognitive enhancement without raising heart rate, suppressing appetite, or causing anxiety. It creates a calm but sharp mental state
·         Sustained Effect — With consistent use, benefits tend to increase over time as functional choline transporter density increases — a true neuroadaptive effect rather than acute stimulation
·         Enhanced Visual Acuity — Many users report sharper, more vivid vision with improved contrast sensitivity and color perception (likely due to its effect on retinal cholinergic transmission)
·         Improved Verbal Expression — Increased verbal fluency, quicker word recall, and more articulate speech are among the most consistently reported benefits
·         Mood Stability — Cholinergic stability supports emotional regulation, calm focus, and reduced mental chatter
·         Low Tolerance Build-up — Unlike many cognitive enhancers, Coluracetam does not lose efficacy with continued use; effects may even improve over weeks to months
·         Neurodegenerative Disease Potential — Clinical research (Phase I and II trials completed) showed promising results for Alzheimer's disease, but development was deprioritized for commercial reasons, not safety or efficacy failure
Who Is It For?·         Advanced nootropic users looking for the most targeted and sophisticated cholinergic nootropic available — Coluracetam is considered a "high-tier" compound in the nootropic community for those who have experience with basic choline sources and racetams
·         Individuals with age-related cognitive decline — Coluracetam's ability to restore impaired HACU function makes it one of the few compounds that addresses the mechanism of age-related cholinergic dysfunction, not just its symptoms
·         Students and professionals in high-demand cognitive roles who need sustained mental performance, enhanced learning capacity, and quick information processing
·         Those who need cognitive enhancement without stimulation — Coluracetam is ideal for those who are sensitive to caffeine, have anxiety, or need to perform cognitive work in the evening without sleep disruption
·         Individuals who have tried other racetams (piracetam, aniracetam, oxiracetam, phenylpiracetam) with limited success — Coluracetam's unique mechanism (HACU enhancement) offers a fundamentally different pathway that may work when other racetams do not
·         Biohackers and longevity enthusiasts seeking to maintain and restore brain function with age
·         Individuals recovering from mild TBI (traumatic brain injury) or concussion — cholinergic dysfunction is a hallmark of brain injury; Coluracetam's restorative effects on HACU may support recovery (under medical supervision)
·         Glaucoma patients or those concerned about eye health — Coluracetam's retinal neuroprotective properties offer potential for visual health support
·         Anyone experiencing "brain fog" of unknown origin — particularly when brain fog is associated with cholinergic insufficiency (common in aging, stress, and post-viral syndromes)
·         Those seeking a non-stimulant alternative to modafinil, methylphenidate, or other prescription cognitive enhancers
·         Writers, artists, and creative professionals — many report enhanced verbal fluency, idea generation, and reduced mental blocks
Instructions for UseRecommended Dosage
Timing
Course Duration
1 capsule (30 mg) per day
Take in the morning with or without food
Can be taken long-term; effects may increase over 2–8 weeks
Usage Notes:
·         Take in the morning — While Coluracetam is non-stimulating for most users, it can be mildly alerting. Morning administration aligns with natural cholinergic peaks
·         Can be taken with or without food — Coluracetam is well-absorbed regardless of food intake. However, taking it with a meal containing some fat may slightly improve absorption (Coluracetam has some lipophilic character)
·         Acute vs. Chronic Effects — Coluracetam differs from most nootropics in that:
o    Some acute effects (cognitive clarity, verbal fluency, visual enhancement) may be noticeable within 30–90 minutes of the first dose
o    Full benefits (increased synapse density, restored HACU function, enhanced cognitive capacity) develop over 2–8 weeks of consistent use as functional choline transporter density increases
·         Consistency is critical — Coluracetam's unique mechanism (upregulating choline transporter function) requires sustained administration for optimal effect. Sporadic use will not produce the same benefits as consistent daily intake
·         Does not require additional choline supplementation — unlike piracetam and other racetams, Coluracetam increases the neuron's ability to acquire choline, making standalone use effective. However, some users still benefit from adding a basic choline source (Alpha GPC, CDP-Choline) for additional support
·         Stacking synergy — Coluracetam pairs exceptionally well with:
o    Alpha GPC or CDP-Choline — provides substrate for upregulated HACU system
o    Noopept — complementary cognitive pathways
o    PRL-8-53 — for memory hyper-consolidation stacks
o    Bacopa monnieri — long-term memory encoding support
o    L-Theanine — calm focus synergy
·         Can be cycled or taken continuously — due to its mechanism (transporter upregulation rather than receptor agonism), Coluracetam does not cause tolerance in the traditional sense. Some users take it continuously, others cycle 8–12 weeks on / 1–2 weeks off
·         For best cognitive results — combine with adequate sleep, hydration, and regular aerobic exercise (all of which increase brain-derived neurotrophic factor and support cholinergic function)
Precautions·         Consult a healthcare professional before use if you:
o    Have a history of seizures or epilepsy — racetam-class compounds may lower seizure threshold in susceptible individuals
o    Are taking anticholinergic medications (diphenhydramine, tricyclic antidepressants, antipsychotics, oxybutynin, scopolamine) — Coluracetam may counteract these
o    Have bipolar disorder — cholinergic compounds may influence mood cycling
o    Have liver or kidney disease — Coluracetam is metabolized hepatically and excreted renally
o    Are taking blood-thinning medications — theoretical interaction
o    Have glaucoma or retinal conditions — Coluracetam is being researched for ocular neuroprotection, but consult your ophthalmologist before use
·         Possible side effects are generally mild and dose-dependent:
o    Headache — the most common side effect, typically occurring at higher doses. If headache occurs, reduce dose or ensure adequate hydration. This is a sign of cholinergic overstimulation
o    Mild nausea or digestive upset — uncommon at 30 mg
o    Increased salivation — a sign of cholinergic activation, generally mild
o    Mild muscle tension — particularly in the neck, jaw, or shoulders (cholinergic neuromuscular activation)
o    Visual effects — some users report sharper vision, increased color vibrancy, or mild light sensitivity. Generally welcomed but can be disorienting initially
o    Dizziness or lightheadedness — rare, typically resolves within days
o    Insomnia — if taken too late in the day
·         Cholinergic overdose symptoms — at very high doses (substantially exceeding recommended levels): excessive salivation and sweating, muscle fasciculations, bradycardia, lacrimation, diarrhea, blurred vision. Extremely rare at recommended dosages
·         Not for acute pre-workout use — while Coluracetam enhances neuromuscular function, it is not a stimulant and will not provide the acute intensity boost expected from pre-workout formulas. Its benefits for physical performance are more subtle and cumulative
·         Pregnancy and breastfeeding — safety has not been established. Coluracetam was tested in clinical trials but not in pregnant or lactating populations. Consult a healthcare provider
·         No known interaction with alcohol — but avoid combining with CNS depressants until individual tolerance is established
·         Do not exceed recommended dose — Coluracetam's effects do not improve linearly with dose. Higher doses (60+ mg) may cause more side effects without additional benefits. 30 mg is the well-established effective dose
·         Keep out of reach of children
·         This product is a dietary supplement (research compound) and is not intended to diagnose, treat, cure, or prevent any disease